Hull Royal Infirmary is a tertiary teaching hospital and is one of the two main hospitals for Kingston upon Hull. It is situated on Anlaby Road, just outside the city centre, and is run by Hull University Teaching Hospitals NHS Trust.

There are 700 beds in Hull Royal Infirmary.

During the past decade, Hull Royal Infirmary conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 20 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 13 clinical trials were completed. i.e. 61.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hull Royal Infirmary" #1 sponsor was "Hull University Teaching Hospitals NHS Trust" with 9 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "University of Hull" with 4 trials sponsored and "University of Oxford" with 4 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hull Royal Infirmary" #1 collaborator was "University of Hull" with 5 trials as a collaborator, "Lymphoma Trials Office" with 3 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 2 trials as a collaborator, "Cancer Research UK" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "Hull Royal Infirmary" are "Lymphoma" (9 trials), "Varicose Veins" (4 trials), "Abdominal Aortic Aneurysm" (3 trials), "Breast Cancer" (3 trials) and "Renal Failure" (3 trials). Many other conditions were trialed in "Hull Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Hull Royal Infirmary" are "Drug" (50 trials), "Procedure" (17 trials), "Biological" (12 trials), "Other" (12 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "cyclophosphamide" (7 trials), "doxorubicin hydrochloride" (5 trials), "etoposide" (5 trials) and "vincristine sulfate" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hull Royal Infirmary" are 82 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hull Royal Infirmary". undefined are not yet recruiting, 11 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Hull Royal Infirmary, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hull Royal Infirmary, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 19 trials that are defined as “Not Applicable".